Negative result in search for human alpha-dystrobrevin deficiency [2]

Muscle and Nerve

Volumn 28, Issue 3, 2003, Pages 387-388

  Ishikawa, Harumi ^a,b   Nonaka, Ikuya ^a   Nishino, Ichizo ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DYSTROBREVIN; DYSFERLIN; DYSTROPHIN; MEMBRANE PROTEIN; MEROSIN; POLYCLONAL ANTIBODY; SARCOGLYCAN; UNCLASSIFIED DRUG;

ALPHA DYSTROBREVIN DEFICIENCY; ANIMAL MODEL; ANIMAL TISSUE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LETTER; MALE; MOUSE; MUSCLE BIOPSY; MUSCLE DISEASE; MUSCULAR DYSTROPHY; NONHUMAN; PROTEIN DEFICIENCY; SARCOLEMMA;

ADULT; CALPAIN; CYTOSKELETAL PROTEINS; DYSTROPHIN-ASSOCIATED PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE PROTEINS; MUSCLE FIBERS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; MUTATION; PATIENT SELECTION; PROTEIN ISOFORMS; SARCOLEMMA;

EID: 0041429641     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mus.10441     Document Type: Letter

References (5)

1. Chae J, Minami N,Jin Y, Nakagawa M, Murayama K, Igarashi F, Nonaka I. Calpain 3 gene mutations: genetic and clinico-pathologic findings in limb-girdle muscular dystrophy. Neuromuscul Disord 2001;11:547-555.
2. Grady RM, Grange RW, Lau KS, Maimone MM, Nichol MC, Stull JT, Sanes JR. Role for α-dystrobrevin in the pathogenesis of dystrophin-dependent muscular dystrophies. Nat Cell Biol 1999;1:215-220.
3. Hoshino S, Ohkoshi N, Ishii A, Shoji S. The expression of alpha-dystrobrevin and dystrophin during skeletal muscle regeneration. J Muscle Res Cell Motil 2002;23:131-138.
4. Ozawa E, Nishino I, Nonaka I. Sarcolemmopathy: muscular dystrophies with cell membrane defects. Brain Pathol 2001;11:218-230.
5. Yoshida M, Hama H, Ishikawa-Sakumi M, Imamura M, Mizuno Y, Araishi K, Wakabayashi-Takai E, Noguchi S, Sasaoka T, Ozawa E. Biochemical evidence for association of dystrobrevin with the sarcoglycan-sarcospan complex as a basis for understanding sarcoglycanopathy. Hum Mol Genet 2000;9:1033-1040.